4528 小野薬品工業

累計 / 通期：4Q / 3Q / 2Q / 1Q

決算期	四半期	売上高	営業利益	営業利益率	経常利益	経常利益率	純利益	純利益率	EPS	売上高前年比	営業利益前年比	経常利益前年比	純利益前年比
2026/03	4Q	515,785	92,236	17.9%	-	-	69,767	13.5%	148.49	5.9%	54.4%	0.0%	39.4%
2025/03	4Q	486,871	59,747	12.3%	-	-	50,047	10.3%	106.55	-3.1%	-62.6%	0.0%	-60.9%
2024/03	4Q	502,672	159,935	31.8%	-	-	127,977	25.5%	266.61	12.4%	12.7%	0.0%	13.5%
2023/03	4Q	447,187	141,963	31.7%	-	-	112,723	25.2%	230.85	23.8%	37.6%	0.0%	40.0%
2022/03	4Q	361,361	103,195	28.6%	-	-	80,519	22.3%	162.19	16.8%	4.9%	0.0%	6.8%
2021/03	4Q	309,284	98,330	31.8%	-	-	75,425	24.4%	151.11	5.8%	26.9%	0.0%	26.3%
2020/03	4Q	292,420	77,491	26.5%	-	-	59,704	20.4%	118.47	1.3%	25.0%	0.0%	15.8%
2019/03	4Q	288,634	62,010	21.5%	-	-	51,539	17.9%	100.25	-	-	-	-

決算期	四半期	売上高	営業利益	営業利益率	経常利益	経常利益率	純利益	純利益率	EPS	売上高前年比	営業利益前年比	経常利益前年比	純利益前年比
2026/03	4Q	515,785	92,236	17.9%	-	-	69,767	13.5%	148.49	5.9%	54.4%	0.0%	39.4%
2025/03	4Q	486,871	59,747	12.3%	-	-	50,047	10.3%	106.55	-3.1%	-62.6%	0.0%	-60.9%
2024/03	4Q	502,672	159,935	31.8%	-	-	127,977	25.5%	266.61	12.4%	12.7%	0.0%	13.5%
2023/03	4Q	447,187	141,963	31.7%	-	-	112,723	25.2%	230.85	23.8%	37.6%	0.0%	40.0%
2022/03	4Q	361,361	103,195	28.6%	-	-	80,519	22.3%	162.19	16.8%	4.9%	0.0%	6.8%
2021/03	4Q	309,284	98,330	31.8%	-	-	75,425	24.4%	151.11	5.8%	26.9%	0.0%	26.3%
2020/03	4Q	292,420	77,491	26.5%	-	-	59,704	20.4%	118.47	1.3%	25.0%	0.0%	15.8%
2019/03	4Q	288,634	62,010	21.5%	-	-	51,539	17.9%	100.25	-	-	-	-